Cargando…
Serum Immune Profiling for Early Detection of Cervical Disease
Background: The most recent (2012) worldwide estimates from International Agency for Research on Cancer indicate that approximately 528,000 new cases and 270,000 deaths per year are attributed to cervical cancer worldwide. The disease is preventable with HPV vaccination and with early detection and...
Autores principales: | Ewaisha, Radwa, Panicker, Gitika, Maranian, Paul, Unger, Elizabeth R., Anderson, Karen S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667406/ https://www.ncbi.nlm.nih.gov/pubmed/29109779 http://dx.doi.org/10.7150/thno.21098 |
Ejemplares similares
-
Characterization of the Human Cervical Mucous Proteome
por: Panicker, Gitika, et al.
Publicado: (2010) -
Immunogenicity of CRISPR therapeutics—Critical considerations for clinical translation
por: Ewaisha, Radwa, et al.
Publicado: (2023) -
Delayed dosing intervals for quadrivalent human papillomavirus vaccine do not reduce antibody avidity
por: Brady, Allison M., et al.
Publicado: (2020) -
Sensitive and Specific Peak Detection for SELDI-TOF Mass Spectrometry Using a Wavelet/Neural-Network Based Approach
por: Emanuele II, Vincent A., et al.
Publicado: (2012) -
Antibody persistence after a single dose of quadrivalent HPV vaccine and the effect of a dose of nonavalent vaccine given 3-8 years later – an exploratory study
por: Gilca, Vladimir, et al.
Publicado: (2018)